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ABSTRACT 
Caregiver Selection of Treatments for Their Child with Autism 
Amy Kurowski-Burt 
This project was completed to understand what treatments caregivers are selecting for their child 
with autism and why treatments were selected and discontinued.  Caregivers of children with 
autism participated in a mixed methods study. An online survey was completed (N=127) to 
identify treatments used for their child.  Interviews were completed (n=14) to understand why 
treatments were selected and discontinued. Selection of medical, dietary, therapeutic, 
complimentary/ alternative medicine, community-based, behavioral, and educational treatments 
were mostly influenced by recommendations of others.  Caregivers reported discontinuing 
because relationships and professionalism were lacking between provider and family.  Providers 
must consider all the variables that influence caregivers’ intervention selection to ensure 
caregiver follow through to encourage change.   
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Caregiver Selection of Treatments for Their Child with Autism 
     Autism Spectrum Disorder (ASD), or autism, is a pervasive neurodevelopmental disorder that 
affects approximately 1 in 68 children and which has no known cure (Centers for Disease 
Control [CDC], 2017).  ASD is prevalent in all demographics for age, race, and region.  Males 
are four times more likely to have an ASD than females.  As per the DSM-V diagnostic criteria, 
a child with impairments in social interaction, communication, and behavior will be diagnosed 
with autism spectrum disorder.  Severity must also be identified by assigning a level of 1-3, with 
level 3 indicative of marked deficits in the three areas listed previously (Autism Speaks, 2018).  
This is a spectrum disorder due to the variability in symptoms from one person to another.  Prior 
to the DSM-V, children were identified with autistic disorder, Asperger syndrome, or pervasive 
developmental disorder- not otherwise specified (PDD-NOS, American Occupational Therapy 
Association [AOTA], 2018).  For purposes of this research study, the prior diagnostic criteria 
labels will be used at times when discussing the diagnosis and treatment because most of the 
literature was written in accordance with the DSM-IV.      
     Due to the impact on child functioning and socialization, caregivers may seek radical 
treatments more so than with other disabilities or diagnoses.  With minimal outcomes observed 
or noted by the caregivers, treatments may be frequently discontinued and added.  Professionals 
who assist their clients in finding treatments to help with autism should focus on patient and 
family goals.  Recommended treatments should be reasonable given the available resources of 
the family (Lancaster, 2005; Mire, Raff, Brewton, & Goin-Kochel, 2015).   
     Understanding the reasons why families select particular treatments for autism and the 
impacts these decisions have on child and family daily living will enhance service providers’ 
understanding of the barriers encountered, the family’s goals, and the impact of these strategies 
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on daily living, which are of vital importance for service providers to consider when working 
with these families (Case-Smith & Arbesman, 2008; Tomchek, LaVesser, & Watling, 2010. 
Caregivers’ Selection of Treatments for Autism 
    Treatments for autism are typically sought to remediate the core symptoms of autism: poor 
social reciprocity and communication, and repetitive behaviors (Gaspar Al Alba & Bodfish, 
2011).  Related goals of these treatments also may be to improve functional independence, 
quality of life, and to diminish family stressors related to the diagnosis (Myers & Plauche 
Johnson, 2007).  Parents’ treatment priorities may center on their child’s adaptive skills and 
specific behaviors related to performance for these skilled areas if they are delayed or 
emerging.   Parents have reported trying a variety of treatments through trial and error, in the 
hope that something works (Hoogsteen & Woodgate, 2013). 
     Another approach for treatment selection is based on the comorbidities associated with autism 
(Levy, Mandell, & Schultz, 2009; Myers & Plauche Johnson, 2007).  These comorbidities are 
classified as developmental, psychiatric, behavioral, sensory, neurological (i.e., seizures), 
gastrointestinal, and sleep. Specific treatments related to these associated conditions may help 
alleviate the symptoms and also may indirectly impact the autistic behaviors related to poor 
socialization, poor communication, and repetitive behaviors.  Treatments must match the 
family’s beliefs, priorities, and routines or they will be more of a hindrance than beneficial 
(Goin-Kochel, Mackintosh & Myers, 2009).  
   Another consideration is that children with autism are often involved in multiple, different 
treatments.  This makes it difficult to attribute observed changes to a specific 
intervention.   Parents have reported using two to nine different treatments at one time (i.e., 
Bowker, D’Angelo, Hicks, & Wells, 2011; Rogers & Vismara, 2008). Green et al. (2006) also 
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studied treatment selection for autism and described that the highest number of interventions 
reported from their survey of 111 options was 47 treatments currently used and 39 in the past.   
     Age and severity of autism also influence the number of treatments used.  Specifically, 
younger children tend to be enrolled in more treatment activities, whereas older children with 
autism may have fewer treatments due to exhaustion of or lack of helpful treatments (Green et 
al., 2006).  Research suggests that unsubstantiated treatments were rarely considered by 
caregivers during adolescence (Goin-Kochel, Myers, & Mackintosh, 2007). 
    Davis (2010) described four potential influences on parental choices of treatments for their 
child with autism, providing insights into parents’ frequent use of unsupported treatments.  First, 
parents of children with autism experience high levels of stress and they may select treatments 
out of feelings of desperation and therefore willing to try almost anything.  Second, parents do 
not want to think “what if I tried this?”  Therefore, parents want to try everything possible in 
case that is the answer to their child’s difficulties.  Third, parents select treatments without strong 
knowledge of any available empirical evidence, evidence-based practices, or of the autism 
diagnosis itself.  Finally, parents are confused by contradictory professional opinions regarding 
the variety of treatment options. Understandably, they often make decisions based on 
information gleaned from a variety of sources such as the internet, other families, or therapists 
(Davis, 2010; Green, 2007).  The complexity of the diagnosis with its’ variability of symptoms 
may influence parents’ views about treatments and lead them to believe that they just need to 
find the right combination of treatments to fit the unique needs of their child (Davis, 
2010).  Gaspar Al Alba and Bodfish (2011) found that if parents were surprised by the diagnosis 
of autism, they tended to select treatments that focused on the education environment.  However, 
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parents who suspected their child of having autism prior to the diagnosis focused on etiology, the 
risk of siblings having ASD, and receiving more education about the diagnosis. 
Caregivers’ Reasons for Discontinuing Treatments 
     Parents reported discontinuing treatment for their child with autism due to the following 
reasons: lack of measurable progress, treatment no longer needed due to observed progress or 
other changes, desire to continue but could not due to factors outside of their control (e.g., 
moving to a new house, sudden illness or death in family), side effects were too severe, treatment 
was aversive, cost was too high, or the child’s willingness to comply was poor (Bowker et al., 
2011; Wong & Smith, 2006). Medications were the most common treatment to be discontinued, 
followed by alternative diets, and physiological treatments.  Reasons for stopping treatments 
were mostly attributed to lack of visible progress.  However, treatment duration was not 
considered; most treatments do not result in instantaneous changes and require time before any 
effects may be observed.  In one study, parents reported that participation in treatments for 
autism varied from a few days to many years (Wong & Smith, 2006).   
   Stressors that may influence discontinuation of treatment are the child or family’s responses to 
diagnostic and intervention services, child rearing abilities, financial status, rigid routines, respite 
care, parents’ work, and family socialization (Kuhaneck, Madonna, Novak, & Pearson, 
2015).  Stressors are also commonly related to siblings’ presence in the home.  Parents are 
fearful that their attention to their child with autism takes away from their other child(ren)’s 
needs.  Treatments may be discontinued due to these added stressors which, in turn, confound the 
family’s attention to the needs of the child with autism (Kuhaneck & Britner, 2010).  
Treatments for Autism 
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     Autism presents in multiple ways.  Every person with autism has unique personal 
characteristics, comorbidities, and family situation.  Therefore, each individual with autism 
requires a personalized treatment plan to address this complexity (Autism Speaks, 
2018).  Currently, there are over 130 different treatments being used to treat autism.  Families 
reportedly are trying numerous treatment strategies for their child with autism and determining 
for themselves which is most beneficial rather than waiting for evidence of effectiveness to be 
developed.  Caregivers are constantly searching for those treatments that will yield positive 
change for their child (Goin-Kochel et al., 2007).   Best outcomes are observed when caregivers 
are trained to take an active role in the selected treatments (Case-Smith & Arbesman, 2008; Levy 
et al., 2009).  Also, understanding parental beliefs about the child’s disability may assist with the 
development of appropriate family treatments that can alleviate stress and promote family well-
being (Al Anbar, Dardennes, Prado-Netto, Kaye, & Contejean, 2010). 
    Professionals who work with children with autism (e.g., teachers, pediatricians, therapists) 
must also consider the variety of treatments that families may use in varying combinations 
(Goin-Kochel et al., 2007).   On one hand, “combining treatments may be an effective and 
necessary way to treat these complex disorders, yet little is known about the safety and efficacy 
of combining treatment approaches” according to Bowker et al. (2011, p. 1379).  On the other 
hand, the use of multiple treatments for autism at once can be harmful and 
counteractive.  Sometimes combining treatments prevents optimal outcomes or limits resources 
(Call, Delfs, Reavis, & Lomas-Mevers, 2015). Combining treatments may also hinder the ability 
to determine any specific intervention’s effects on observed outcomes.   
     It is important to note that multiple professionals- even from the same profession- may be a 
part of the intervention team for a child with autism (e.g., a school-based occupational therapist 
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and an outpatient occupational therapist).  Professionals should support families through the 
effective coordination of care to address the multiple needs and symptoms related to the child’s 
autism.  Families must be aware of any contraindications with care (e.g., counterproductive 
techniques, medication interactions) and encourage collaboration with the team members, 
including the caregivers and child with autism.  Green et al. (2006) suggested that practitioners 
should understand the parents’ decision processes for treatment selection to better serve the 
population with autism.   
     Treatments can be categorized based on their area of emphasis for disease or disability 
management, setting in which they occur, or methodology and/or theories used.  For purposes of 
this study, treatments for autism were categorized into seven main areas: behavioral, educational, 
medical, dietary, therapeutic, community-based, and complementary/ alternative medicine.  
Categorization of the treatments were determined through a systematic review process of the 
literature.  Refer to Appendix B for the list of treatments within the categories.  
Behavioral Treatments 
     Behavioral treatment is a widely used, empirically-based, successful treatment intervention 
for children with autism.  These methods do not have strong evidence for elimination of the 
symptoms of autism, but have been shown to reduce undesirable behaviors and improve 
academic performance.  Behavior therapies are highly structured, define expectations clearly, are 
organized hierarchically, include measurable goals, and are easily integrated (Levy et al., 2009; 
Sheinkopf & Siegel, 1998).  Implementing behavioral-focused treatments is beneficial to assist in 
developing the child’s communication and social skills, as well as for decreasing harmful 
reactions (e.g., self-injurious behaviors) that are unsafe and unhealthy (Lancaster, 
2005).  However, such treatments require significant time to implement and for carryover into 
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multiple environments to be effective.  Recommended time with a trained professional is 20-25 
hours per week (Autism Speaks, 2018).  Also, these programs have limited generalizability of 
skills into the community due to the high structure for implementation (Levy et al., 2009).  The 
most frequently used behavioral treatments are the Lovaas Model (aka Applied Behavioral 
Analysis), Early Start Denver Model, floortime (DIR), and verbal behavioral therapy (Autism 
Speaks, 2018). 
Educational Treatments 
    The educative treatments not only address academic learning, but may also impact social 
skills, self-care skills, communication, behaviors, and generalization of these skills across a wide 
range of environments (Myers & Plauche Johnson, 2007).   Early participation in structured 
educational programming has been strongly supported to be effective for better outcomes later.   
     The following is a listing of attributes and considerations that have been deemed as effective 
components in early education programs for children with autism.  Children should begin these 
types of programs as soon as autism is suspected; families should not wait until a definitive 
diagnosis is given.  The program should be intensive, developmentally appropriate, and 
systematically planned with specific objectives and a low student-to-teacher ratio with 
opportunities for small group activity. Opportunities for interactions with typically developing 
peers during specific education activities, as well as incorporating high levels of structure are 
reported as being effective components for early educational programs.  These programs should 
use strategies that enable the child with autism to generalize the learned skills to new 
environments and situations.  All of these aspects of these programs should include the family 
and provide training to assist with carryover in the home.  Assessment-based curricula should 
guide the educational program and include communication, social skills, adaptive skills, behavior 
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management, cognition, and developmentally appropriate readiness and academic skills (Myers 
& Plauche Johnson, 2007).              
Medical Management and Treatments 
     Attending to the medical needs of a child with autism can promote overall improvement of 
developmental skills, behaviors, and quality of life.  Management of acute illness, sleep 
dysfunction, behaviors, psychiatric conditions, associated medical problems, as well as 
preventative care can positively influence children’s progress, especially their educational 
outcomes (Myers & Plauche Johnson, 2007).  Medical management can be most effective in 
treating autism if there is an understanding of the neurophysiolopathology of core symptoms as 
well as the pharmacogenetic approaches while considering the family history of drug 
responsivity (Palermo & Curatolo, 2004). 
     Pharmacological treatments for autism are  used to treat the core symptoms and comorbid 
conditions such as attentional difficulties, hyperactivity, affective difficulties, depression, 
repetitive behaviors, irritability, aggression, anxiety, self-injurious behavior, behavioral cycling 
between rage and euphoria, social impairment, destructive behaviors, and sleep disruption (Chez, 
Memon, & Hung, 2004; Levy et al., 2009; McDougle, Stigler, Erickson, & Posey, 2006; Myers 
& Plauche Johnson, 2007; Palermo & Curatolo, 2004).  Efficacy of using pharmaceutical 
treatments for autism is well documented (Truven Health Analytics, 2018), however, using 
medication has been noted to be a last resort option for treatment selection by caregivers (Goin-
Kochel et al., 2007).       
Therapeutic Treatments 
      Therapy includes a variety of services through the lifespan, beginning at birth.  Children with 
special needs may require speech and language therapy (SLT) to address social communication 
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deficits, making it the most sought after therapy for autism (Tomchek et al., 2010).   Use of 
augmented and alternative communication methods have limited published evidence; however, 
use of these devices can support learning to talk and help children understand symbolic 
communication (Myers & Plauche Johnson, 2007).   
     Another frequently used therapy for autism is occupational therapy (OT), which provides 
effective support, resources, and advocacy to individuals with autism (Tomchek et al., 2010). 
One-on-one treatment sessions are more widely used by therapists than treatment in small or 
large groups.   If groups are used, small ratios have been most effective (Watling, Deitz,, Kanny, 
& McLaughlin, 1999). Other examples of therapeutic treatments for autism are music therapy, 
therapeutic riding, counseling, interactive metronome, sign language, facilitated communication, 
and exercise.  
Dietary 
     Most children with autism have selective diets, but malnutrition is unlikely (Myers & Plauche 
Johnson, 2007).  Children with PDD-NOS were more likely to be placed on specialized diets 
(i.e., gluten free, yeast free, Feingold diet) than children with Asperger’s and autism (Bowker et 
al., 2011).   Hendren (2015) discussed when children with autism showed benefits (i.e., 
nutritional and metabolic status) after being given supplements. This may assist with protein and 
peptide digestion, especially for children who have gastrointestinal issues.  By improving the 
function of the gut, better brain functioning is enabled through improvements in the production 
of amino acids: the gut-brain connection.  Supplements with the most consideration from 




    Individuals with autism and their families may have goals of being contributing members to 
society.  Most adults with autism live with their parents or in community supportive living.  A 
small percentage are employed and if they work many receive below average wages which 
impedes independent living (Taylor et al., 2012).  Despite this, adolescents and young adults 
with autism can learn strategies to improve their chances to obtain paid employment.  These 
situations can be either independent or supported employment.  Employment has been shown to 
improve quality of life, autistic symptoms, and executive functioning skills in people with autism 
(Weaver, 2015).  Supported employment is more beneficial to people with autism than sheltered 
workshops with a work focus.  Supported employment also is more beneficial than independent 
work because many individuals with autism live a dependent life (Taylor et al., 
2012).  Technology has been reported to be an effective tool for vocational skill attainment 
(Weaver, 2015).  
Complementary and Alternative Treatments     
     Complementary and alternative treatments (CAMs) are described as medical care that is not 
standard practice, which can complement standard medical treatments, or be used instead of 
standard treatments (National Institutes of Health, 2015).  Levy et al. (2009) stated that parents 
seem to select CAMs more often in association with autism than for any other childhood 
disability or disorder, even before receiving an official diagnosis.  However, many of these 
treatments do not have strong evidence to support positive outcomes.  Caregivers of children 
with autism most likely learn about these treatment options through networks with other parents 
or via the internet (Harrison & Zane, 2018; Wong & Smith, 2006) in which case the scientific 
evidence that supports these treatment options may be missing, misreported, or ignored.  More 
than 50% of families with children with autism have used CAMs (Harrison & Zane, 
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2018).  Parents’ decisions to use CAMs for their child were correlated with education level of the 
parents and parents’ use of CAMs for themselves, and related to the non-curative nature of 
autism (Wong & Smith, 2006).         
    CAMs are divided into biological and non-biological categories.  Biological treatments 
include immunoregulatory treatments, detoxification therapies, gastrointestinal treatments, and 
dietary supplements.   Examples include supplements such as B6, magnesium ion, dimethyl 
glycine, and cod-liver oil; antibiotics, antifungals, antivirals, and immunoglobulins; 
gastrointestinal medications; chelation; hyperbaric oxygen chambers; and withholding of 
immunizations.  Non-biological alternative treatments include manipulative, body-based, mind-
based, and energy medicine.  Examples of these include chiropractics with craniosacral 
manipulation, auditory integration, yoga, behavioral optometry, animal-assisted therapy, music 
therapy, massage, qigong, interactive metronome, reiki, and transcranial stimulation (Levy et al., 
2009; Myers & Plauche Johnson, 2007).   
     This study examined caregivers’ perspectives regarding selection of treatment for their 
children with autism by (a) identifying what treatments that caregivers report most frequently 
selecting to treat their child with autism, (b) identifying why specific treatments are selected, and 
(c) identifying why the treatments are discontinued.   The survey used in the current study listed 
133 treatments that caregivers could report using currently or having previously used for their 
child with autism.  While other studies have sought to understand why parents select particular 
treatments (e.g., Bowker et al., 2011; Green et al., 2006).  However these studies have only 
selected a small number of autism treatments as part of their survey (e.g., Bowker et al., 2011; 
Goin-Kochel et al., 2007); have focused on specific treatments categories such as educational 
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treatments (e.g., Hess, Morrier, Heflin, & Ivey, 2008; Pituch et al., 2011); or focused on a 
specific age such as early intervention (e.g., Rogers & Vismara, 2008). 
Method 
     A sequential explanatory mixed methods research design with semi-structured interviews 
following an online survey was implemented (Greene, Carracelli, & Graham, 1989). Interview 
participants were purposefully sampled based on survey response profiles (see Figure 1 for 
design). 
 
Fig. 1 Sequential Explanatory Mixed Methods Design 
Participants 
     Participants for the survey (N=127) were recruited by advertising on Facebook, the Autism 
Speaks website, and through the investigator’s personal contacts at various pediatric clinics and 
schools throughout the U.S.  There were 174 caregivers who completed the survey, but 47 could 
not be used due to incomplete information or duplication between father and mother of a given 
autistic child.  For the duplications, the first survey completed as per the time stamp on Qualtrics 
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was the data used for this study.  There were 100 mothers (78.74%), 16 fathers (12.60%), three 
adoptive mothers (2.36%), one grandmother (0.79%), four aunts (3.15%), one sibling (0.79%), 
and two guardians (1.57%).  Of these respondents, 117 (92.86%) were white, five (3.97%) were 
Hispanic/ Latino, two (1.59%) were black/ African American, two (1.59%) identified as other, 
and one participant preferred not to answer. The participants were located in the following states: 
67 from West Virginia; 28 from Pennsylvania; five from Ohio; two each from North Carolina, 
South Carolina, Kentucky, Nebraska, and Florida; and one each from Colorado, Michigan, 
Massachusetts, California, New York, Texas, Washington, and Alabama.  Nine caregivers did 
not identify their location.  Participants’ median household income was $50,000-$74,000.  
Education level of the survey respondents were: one completed some high school, 32 graduated 
from high school, 10 completed vocational school, 28 graduated with an associate’s degree, 29 
with a bachelor’s degree, 20 with a master’s degree, and 5 with a doctorate. Two participants 
preferred to not answer.   
     The children with autism that the caregivers reported on included 101 males and 22 females; 
4 respondents did not identify their child’s gender.   Five of the children reported on were 
toddlers (1-3 years old), 20 were preschool aged (3-5 years old), 57 were school aged (5-11 years 
old), 32 were adolescents (12-17 years old), and nine were young adults (older than 18).   
     The interview sample (n=14) consisted of 13 biological mothers and one grandmother, and all 
were Caucasian.  They were located in West Virginia (n=6), Pennsylvania (n=4), Nebraska 
(n=1), North Carolina (n=1), New York (n=1), and Colorado (n=1).  Three caregivers completed 
a high school education, two with a vocational education, three with an Associate’s degree, two 
with a Bachelor’s degree, two with a Masters, and two with a Doctorate.  The children whom 
were reported on were 11 males and three females, of which three were identified with level 1 
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ASD, five with level 2, two with level 3, and four with an unknown level of ASD.  One child 
was a toddler, two children were of preschool age, six were school-aged, three were adolescents, 
and two were young adults.  
     The inclusion criterion was that their child had been diagnosed as having autism.  Children 
could be of any age.  Parents who agreed to complete the online survey consented to their 
participation by proceeding to Question #1 after reading the introduction script and selecting “I 
agree to participate.”   Participants for the interview were selected among caregivers who 
completed the survey and reported that they were willing to participate in a phone interview.  Of 
the 127 participants who completed the online survey, 86 (67.7%) reported they were willing to 
participate in a phone interview. Interview participants were purposefully selected to include 
seven respondents who selected treatments most commonly selected within each intervention 
category and an additional seven respondents who selected treatments that were least commonly 
selected by the total sample. 
Measures 
     An online questionnaire designed by the researcher was deployed on the Qualtrics platform.  
The questionnaire included Likert scale items, multiple choice selections, and brief narrative 
answers.  Questions included: demographics of the family and child with autism including 
medical history and current functional level, information about the treatments previously used or 
currently being used, and personal perspectives on the autism diagnosis.  The list of treatments 
on the survey was derived through a systematic review process via the university’s library 
website using the keyword combinations of autism, autism spectrum disorders, ASD, 
intervention, treatment.  Pilot testing was completed with five caregivers of children with autism 
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to assess content validity and determine that the survey items were applicable to the topic of 
study and easily understood by the participants.    
     Selected caregivers also participated in semi-structured telephone interviews to gather more 
personal information in regards to treatment selection and discontinuation for their child with 
autism.  An introduction script was used prior to asking the guiding questions for the semi-
structured interview to build rapport with the participants (See Appendix A). 
Procedure    
     Approval from the Institutional Review Board was obtained prior to data 
collection.  Participants were recruited through advertising with Autism Speaks, on Facebook, 
and through personal contacts at various pediatric clinics and schools throughout the US.  
Participants consented to participate by selected “I agree to participate” after reading a cover 
letter for the study which was included as the first page on the Qualtrics survey.  All participants 
were also screened for inclusion criteria by answering the first question on the questionnaire: 
“Do you have a child with autism.”  If the participant answered “no”, the questionnaire ended. 
     Once the questionnaire screening was completed to identify participants for the high and low 
frequency groups, a sub-sample was purposefully selected to form the group of participants to be 
interviewed.   All interview participants were consented at the beginning of the interview.  The 
telephone interviews were tape-recorded and transcribed by the researcher. 
        Respondents who completed the survey were subsequently emailed a $10 Amazon gift card, 
and those who completed the phone interview received a $30 gift card.  This project was funded 




      Descriptive statistics were compiled on caregiver and child characteristics (e.g., caregiver 
education, household income, ethnicity, and child gender, age, and ASD-specific 
diagnosis).   Response frequencies were determined for each identified intervention (e.g., ABA, 
occupational therapy, gluten free diet, TEACCH, massage) and category type (i.e., medical, 
dietary, therapeutic, complementary/ alternative medicine (CAM), community-based, behavioral, 
and educational), based on level of use (i.e., tried, but not currently using; currently trying; see 
Appendix B).  An independent samples Kruskal-Wallis H-Test was completed to determine 
whether a significant difference was present among treatment categories for treatments used by 
caregivers.   Lastly, frequency counts were computed from the interview questions.  The answers 
to the interview questions were coded based on a content analysis following Kvale and 
Brinkmann’s (2009) methodology.  Open coding for common themes relating to reasons for 
selection and discontinuation was done, as well as selective coding of reasons why treatments 
were used.  Frequency counts were computed for thematic codes (quantitization) following 
Sandelowski, Voils, and Knafl (2009).  
Results 
Treatments Used: Past and Present 
     Caregivers reported currently using treatments based on overall treatment category as follows: 
educational (28%), community (27%), therapeutic (26%), behavioral (21%), medical (21%), 
dietary (20%), and CAMs (12%).  They also reported treatments tried but not currently using as 
follows: therapeutic (20%), dietary (17%), educational (17%), behavioral (16%), medical (12%), 
community 11%, and CAMs (6%, see Figure 2). A Kruskal-Wallis H-test showed no statistically 
significant difference in usage (past and current) across treatment categories for the overall 




Fig. 2 Comparison of percent use of treatments currently using verses tried but not currently by 
caregivers of children with autism (n=127) 
     Thirty-one children were identified as level 1 ASD, 30 with level 2, and 23 with level 3.  Two 
participants classified their child as having Atypical Autism, and 41 participants reported not 
knowing the level associated with the ASD diagnosis, which data were not used for this analysis.      
A Kruskal-Wallis test showed no significant difference in the number of treatments used across 
levels of ASD (p = .261).  Level 1, 2 and 3 ASD utilized treatments disaggregated by category as 
follows respectively: medical (25%, 26%, 25%), dietary (30%, 31%, 21%), therapeutic (33%, 
34%, 34%), CAM (13%, 9%, 13%), community-based (27%, 29%, 24%), behavioral (21%, 36%, 
19%), and educational (27%, 37%, 33%).  A Kruskal-Wallis H-test showed that there was a 
statistically significant difference between therapeutic intervention use and CAM use across 
levels of ASD (p = 0.009); all other comparisons were not significant (Refer to Figure 3). On 
average, level 1 ASD children used (past and present combined) 34.06 treatments, level 2 used 




























Currently using Tried but not currently using
18 
 
ASD reported that their children responded negatively to behavioral interventions whereas this 
was not a topic of discussion for other levels of ASD.   
 
Fig. 3 Percent use of treatments for autism by intervention category for each level of ASD 
diagnosis (level 1, n = 31; level 2, n = 30; level 3, n = 23) 
     Of the 133 autism treatments listed on the survey, caregivers reported medication and a 
psychologist (57%) as the most frequently used medical intervention, followed by a psychiatrist 
(53%) and a neurologist (46%).  The most frequently used dietary treatments were vitamins and 
supplements (72%), gluten free diet (39%), and a nutritionist (35%).  The caregivers reported 
using occupational therapy the most as a therapeutic intervention (89%), followed by speech and 
language therapy (84%), and early intervention (72%).  For CAMs, the most frequently used 
treatments were reported to be relaxation techniques (e.g., deep breathing, 60%), then 
aromatherapy (39%), and yoga (27%).  Advocacy support (63%), autism support groups (58%), 
and religious and spiritual activities (43%) were reported to be the most frequently used 
community-based treatments for autism.  The most common behavioral treatments the caregivers 
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(54%), and applied behavioral analysis (ABA, 50%).  For education treatments, Individualized 
Education Programs (IEPs, 72%) were used the most, followed by school-based speech therapy 
(70%), and school-based occupational therapy (67%, see Figure 4).  It is important to note that 
some survey respondents listed home schooling (n=12) as a treatment although this was not 
included on the survey.  Interview participants also mentioned home schooling (n=6) as a 
treatment used when support in public education was not optimal for their child with autism. 
 
Fig. 4 Percent use of the most frequently used treatments by category. (suppl- supplements, GF- 
gluten free, OT- occupational therapy, SLT- speech language therapy, EI- early intervention, 
ABA- applied behavior analysis, IEPs- individualized education program, CAMs- 
complementary and alternative) 
      Intravenous chelation (4%), transfer factor pentoxifyllinbasic fibroblast growth factor 
(BCGF, 6%), and chelation pills (6%) were reported to be the least frequently used medical 
treatments.  For dietary, the Feingold diet (6%), yeast free diet (13%), and low carbohydrate or 
carbohydrate free diet (17%) were the least used.  The smallest frequency use of therapeutic 
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therapy (12%). Few caregivers reported using transcranial stimulation and qigong (4%), and 
acupuncture, Buddhist monk interactions, and Watsu (5%).  Among community-based 
treatments, sheltered workshops (4%), supported employment (10%), and job coaching (13%) 
were least used.  Least used behavioral treatments were enriched supportive therapy (EST, 7%), 
cognitive enhancement therapy (CET) and pivotal response training (9%), and neurofeedback 
(12%).  Finally, partial hospitalization (6%), Son-Rise program and weekend school support 
services (9%), and responsive teaching (10%) were the least-used educational treatments for 
children with autism (see Figure 5).  
 
Fig. 5 Percent use of the least frequently used treatments by category. (BCGF- transfer factor 
pentoxifyllinbasic fibroblast growth factor, EST- enriched supportive therapy, CET- cognitive 
enhancement therapy, CAMs- complementary and alternative) 
     The sample also was divided into groups based on comorbidities of Sensory Processing 
Disorder (n=34), ADHD (n=45), or no comorbidities noted (n=23).  Other comorbidities were 
not consider due to low representation.  Percent use of each intervention category per 
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therapy (38%, 39%, 36%), CAM (15%, 16%, 15%), community (30%, 33%, 25%), behavioral 
(31%, 32%, 25%), education (38%, 39%, 32%; see Figure 6).  On average, children with ASD 
and a comorbidity of sensory processing disorder used 32.91 treatments, those with a 
comorbidity of ADHD used 43.6 treatments, and those with no comorbidities used 37.18 
treatments.  A Kruskal-Wallis test showed no significant difference in number of treatments used 
across comorbidity groupings (p = .220). 
 
Fig. 6 Percent use of treatments for autism by category for comorbidity groups of Sensory 
Processing Disorder (SPD, n = 34) and Attention Deficit Hyperactivity Disorder (ADHD, n = 
45), and no comorbidities noted (n = 23) 
Reasons for Selection of Treatments 
     As per qualitative analysis from the interviews (n=14), caregivers most frequently reported 
they selected treatments based on their own research (n=7), or that they simply went along with 
recommendations of professionals (n=7).  Treatments were also selected based on the desire to 
improve their child’s quality of life for long term impact (n=5) as well as trial and error 
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overloading the child or taking the autism away (n=3), addressing specific deficits (n=3), need 
for professional support (n=3), and resources (n=1).  See Figure 7 for examples given by the 
caregiver interview sample for each theme for selection of treatment for autism.   
Themes for Selection of 
Treatments 
Participant Comments Supporting Theme 
Own research “I want to be an expert on autism. After you get a diagnosis like 
that, you read everything, you look up everything, you ask the 
doctor, friends, just anyway I can get information, I’ll take it.”   
Recommendations of 
professionals 
“We got a new pediatrician and she recommended birth-3 and we 
had PT and the physical therapist was like this is what you need 
to do. …through birth to three we added OT, nutritionist…” 
Improve QOL “He needs a better quality of life. We need the skills, we can’t do 
it without some sort of intervention.” 
Trial and error “…trial and error a lot of times. He is ever changing. … I know a 
lot of people from my job if they suggest something, I’ll try it.” 
Encumber “Also not overloading it, life is worth living, has to be play based 
and fun.” 
“We haven’t done a lot, avoided behavior approaches, don’t want 
to squash his personality and creativeness, we don’t view his 
autism as a failing on his part. Unique challenges and unique 
benefits, interventions are focused on that mindset.” 
Address specific needs “I guess I just thought it would help him with certain things.” 
Need for professional “… then we realized we can’t do this at all, we need help. He 
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support needs a better quality of life.” 
Good use of resources “Just thinking what will help him long term and what is the best 
investment at the time.” 
Table 1. Themes for treatment selection by caregivers of children with ASD for the interview 
sample 
Reasons for Treatment Discontinuation    
Caregivers reported discontinuing treatments due to their child not needing them anymore (n=6), 
lack of child-professional/ parent-professional relationships (n=3), and negative responses to 
treatments (n=3). Provider professionalism (n=2), difficulty in access to treatments (n=2), and 
waste of resources (n=2) were also cited reasons for stopping participation in treatments for their 
child with autism.  See Figure 8 for interview participant quotes to support each theme for 




Participant Comments Supporting Theme 
Not needed “OT twice stopped, both times because they had taught him 
everything they could teach him.” 
"Not much incentive now because of their age.” 
Lack of relationships “The other one [therapist], she and I clashed…” 
“He hated … therapy. If a therapist he likes is leaving it is time to 
stop.” 
Negative responses “That is not what we want. If she needs medicine to function then 




Provider professionalism “… there were many days that she [therapist] wouldn’t even 
show up for the therapy or she would come two days later. She 
would come one out of every 5 times, it was very erratic. I have 
anxiety like terrible and so I would get massively stressed out, it 
just wasn’t helpful to the situation. So we dropped the [therapy].” 
Difficult to access “[We] did gluten free and at that time it was so hard to find the 
food.” 
Waste of resources “We did do music therapy for a while but it got too expensive 
because [its] not paid for by insurance. I wish it was something 
that was covered.  She really loved it. Thirty dollars for a one 
hour session each week. It adds up.” 
Table 2. Themes for treatment discontinuation by caregivers of children with ASD for the 
interview participants 
Discussion 
     This study shows a different perspective of treatment selection from previous studies done on 
this topic (e.g., Bowker et al., 2011; Goin-Kochel et al., 2007; Green, et al., 2006).  Overall, 
therapeutic and educational treatments were most frequently used, while CAMs were used to a 
lesser extent.  Occupational therapy, speech and language therapy, and positive reinforcement 
were the treatments reported to be mostly used for children with autism.   
     Caregivers of level 1 ASD children reported that they most frequently utilized dietary and 
therapeutic treatments. Caregivers of level 2 ASD children most commonly used behavioral and 
educational treatments, and used all treatments, except CAMs, at a higher percentage than the 
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other levels.  Caregivers of level 3 ASD mostly sought out therapeutic and educational 
treatments. CAMs were the least used across all levels possibly due to decreased access and 
awareness of these treatments.  Providers may also refer less frequently to CAMs due to the lack 
of evidence support for effectiveness to impact autism concerns and comorbidities.  Furthermore, 
a high percent of caregivers (n=41, 32.3%) were unaware of their child’s ASD severity level.   
Knowledge of severity, which is related to developmental levels, is an integral part of the 
treatment process to understand limitations and skills of the child for purposes of planning, 
referrals, and progression through intervention (Kelly & Plunkett D’Avignon, 2014).   
     As per this study, caregivers reported using a high number of treatments (average of 37 for 
past and presently used) as compared to previous studies (average of 15 for past and present; 
e.g., Goin-Kochel et al., 2007).  “It is difficult to judge whether these numbers of treatments used 
should be considered too much, too little, or the right amount” (Green et al., 2006, p. 81).  Also, 
each of the 133 treatments listed on the survey were reported as having been used by one or more 
of the caregiver survey respondents.  This raises concerns as some of the treatments are harmful, 
are expensive to implement or maintain, or lack evidence regarding their effectiveness.  
Providers should understand all aspects, variations of, and intervention options available to better 
guide caregivers with supports for their child.  Benefits of using evidence-based practice ensure 
good use of resources and the treatments are efficacious.  “Many health plans apply evidence-
based approaches to coverage decisions” (Garber, 2001, p. 62).  
     Treatments vary in their effectiveness for individuals with autism.  Many autism treatments 
are individually tailored to meet the client’s specific needs.  Without resorting to trial and error, 
caregivers reported that they fear missing the opportunity for change and improvement for their 
26 
 
child.  Another participant eloquently described her challenges with treatments for her son. She 
stated: 
 Nobody could tell me that this could be the best things. Why did I try all these things, in  
desperation…. turn off that noise when you are feeling really desperate and you are more 
vulnerable. …. because you think maybe red dye #40 would be the reason. At some point 
you just grasp at anything that would help. 
Children with ASD present with variability in development.  This unpredictability can cause 
increased stress for caregivers because the inconsistencies can be confusing causing the 
caregivers to reach for solutions (Kelley & Plunkett D’Avignon, 2014).   
     Comorbidities are common alongside of ASD, specifically ADHD and SPD.  Children with 
autism who had a comorbidity of ADHD were more likely to use treatments across the seven 
categories as compared to those children either without comorbidities or having a comorbidity of 
SPD.  Providers for autism should be aware of the comorbid conditions the child has because 
these may be a direct indicator for treatment selection (Gaspar Al Alba & Bodfish, 2011; Pituch 
et al., 2011).  For example, consider two children with distractibility.  One child who has sensory 
processing disorder may be overwhelmed with environmental stimuli and become distracted.  
They may benefit from sensory integration.  Whereas a child with ADHD is also distracted but 
due to attention issues.  These attention deficits could be successfully treated with medication. 
There is value to understanding comorbid conditions to support treatment selection for autism.  
One participant stated: 
 [There] needs to be a little more awareness to other conditions that go along with autism  
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that’s not related to autism. A lot of kids have other medical aspects. Because parents are 
not aware of it …. really try to understand all the variables, what is going on that is 
making this situation so unbearable at this moment to help them.  
The complexity of ASD combined with other diagnoses needs to be considered when developing 
treatment plans, recommendations, mentoring, and educational goals.  Using a needs-based 
phenomenon (i.e., focusing on the person-specific deficits) and emergent skills perspective for 
selecting treatments would enable practitioners to better support caregiver and patient needs 
(Hoogsteen & Woodgate, 2013).   
     An intervention not included in the survey was home schooling. Interview participants 
reported using home schooling either permanently or intermittently throughout their child’s 
education career for a variety of reasons, including bullying, lack of appropriate supports, school 
staff’s underestimation of the child’s abilities, and fear of public schooling.  This concept should 
be an important issue for educational programs to attend to as legal issues can arise.  The 
Individuals with Disabilities Education Act (IDEA, 2004) Part B specifically outlines what is 
required by schools for students with identified disabilities to receive a free appropriate public 
education in the least restricted environment.  IDEA Part B provides guidance for managing 
disputes when services are not rendered or the parents and the school do not agree on necessary 
accommodations.  Through procedural safeguards, dispute resolution options are provided by 
IDEA to guide parents with negotiations for what is best for their child in public education (Lee, 
2019).   
     Children with level 1 ASD are sometimes overlooked by the schools because their child does 
not have an apparent disability. Parents also reported that a lack of knowledge about autism by 
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the school personnel was a frequent deterrent to continuing in the school system.  As one 
participant shared about her son: 
He might be fine one minute and then a fire alarm can go off and he starts holding his 
ears and rocking back and forth. He keeps his composure and he gets upset and busts out 
crying because he has been holding everything in all day. And you try to explain it to the 
school and they say ‘he doesn’t do that here.’ Well of course not because he wants to be 
as normal as he can around the other kids. 
     Another relationship that was disclosed during the interviews was the negative reactions that 
children with level 1 ASD have when given behavioral treatments. These parents reported that 
their child did not benefit from the behavioral treatments. For example, one participant reported: 
 Behavior treatments, none of those things work. His affect is generally flat. You could  
take things away …. [he does] the same behavior with a different medium. I think really 
at the higher end [of the spectrum] …. it’s a very different thing from a nonverbal child, 
so different. 
A consideration regarding this idea would be the concrete, non-pragmatic thinking of level 1 
autistics.  Behavioral treatments, such as reinforcement or punishment, do not make sense 
because children with level 1 ASD see and understand the situation differently; therefore, they 
do not respond as expected but as they understand how their response should be based on their 
experiences. These deficits for level 1 ASD could be associated with the limitations for use and 
understanding of language in regards to context and decreased understanding of nonverbal 
communication (Berenguer, Miranda, Colomer, Baixauli, & Rosello, 2018).   
    Caregivers often learn about new treatments for autism through social networks (e.g., peers, 
support groups), professional networks (e.g., therapists, counselors), and their own independent 
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research (e.g., internet, Wikipedia).  As reported in this study, Fiske (2017) also described that 
parents have been left without guidance after receiving the diagnosis, being left to seek out 
treatment options and supports on their own.  Also, caregivers of children with autism select 
treatments with little guidance from informed professionals.  Parents reported that they teach 
themselves about what needs to be done to assist their child.  Furthermore, some caregivers 
reported that they believed their child’s autism to be a “gift” to their family and, therefore, they 
avoided treatments that might change some of their child’s personal characteristics. Parents 
reported that their child’s autism was empowering for many reasons such as advocacy, 
spirituality, and purpose.   
     There are several challenges associated with the reported reasons for discontinuing treatments 
for autism.  Interview participants reported that the lack of relationships with their service 
providers made them stop.  These caregivers did not consider the benefits gained from these 
services, just that they or their child was not positively engaging with their provider.  Similarly, 
caregivers also reported that they discontinued treatments when the provider lacked 
professionalism.  Both lack of professionalism and lack of rapport with the child with autism and 
their families can be addressed through training, education, and mentorship programs for these 
service providers.  However, with advocacy and team communication these areas can be 
improved on and service providers, such as teachers, pediatricians, therapists, can better serve 
the autistic community as well as increase access to competent autism providers (Kelly & 
Plunkett D’Avignon, 2014).  Being family centered helps family functioning and coping with the 
diagnosis.  “Systematic stressors, such as problems obtaining appropriate diagnoses or services, 
also make parenting a child with an ASD more challenging than it might otherwise be” 




     Limitations included small sample size and limited geographic region surrounding WV and 
PA. Caregivers also may not be aware of other treatments being used within other programming 
(i.e., the specific behavioral educative techniques used in the classroom or in therapy sessions).  
The study relied on caregivers’ self-report data, which is subject to bias due to selective memory 
of participants, social desirability, and other factors that might influence how participants 
responded to the survey and interview protocols.   
Contributions of This Research 
     This study may serve to inform providers (i.e., teachers, therapists, pediatricians, 
psychiatrists) about the reasons why caregivers select particular treatments for their child with 
autism.  This information is important for these providers to know because as there is no known 
cause for autism, and no single intervention has been shown to either cure or directly alleviate 
the symptoms of autism.  Providers should consider all of the factors that may influence 
caregivers’ selection of treatments.  These factors include focus on improved quality of life and 
specific deficit areas of function, trial and errors methods, and good use of resources.  Caregivers 
also emphasize the importance of not restricting their child to only autism focused activities to 
allow them to be who they are meant to be.  Supporting families in the decision-making process 
around treatments will enable more effective parent-provider collaboration, which may 
contribute to better child outcomes.  By having knowledge of how caregivers select treatment, 
providers can intervene at appropriate levels of functioning.  For example, if a teacher is aware 
that their student with ASD is only receiving school-based therapy services with an IEP then 
they can better guide the child’s educational team for supplemental activities to address unmet 
needs.    
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     The study reported here may inform other researchers about the treatments that are being 
selected by caregivers of children with autism.  Some of these treatments may need to be 
examined more closely.  A point topic that arose from the study was the negative perspectives of 
behavioral treatments with level 1 ASD.   Behaviorist can examine their intervention outcomes 
by level of ASD.  Also, if parents frequently use treatments that are harmful, then they need to be 
informed of this harm by pediatricians, psychologists, and other primary referrers.  If caregivers 
use treatments that are wasteful and ineffective, then careful examination and reporting of results 
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1. How would you describe a typical day with your child?  
2. How much help does your child need during the day? With what? How do you help 
him/her?   
3. What are your top three goals for your child?  
4. Please describe reasons for selecting treatments for your child with autism.   
5. Please identify some reasons for stopping treatments?  
6. What changes did you see in your child from the treatments used that you would identify 
as being the most significant? Did you experience any negative outcomes?   
7. Have you as a caregiver (or other caregivers) for your child with autism utilized services 
to assist you with coping or management of your child? 
















Medical Vagal nerve stimulation, psychiatrist, psychologist, neurologist, intravenous 
immunoglobulin (IVIG), transfer factor pentoxifyllinbasic fibroblast growth 
factor (BCGF), medication intravenous chelation, chelation pills, 
detoxification 
Dietary Dietician, nutritionist, gluten free diet, casein free diet, Feingold diet, soy 
free diet, dye free diet, yeast free diet, low carbohydrate or carb free diet, 
artificial sweetener free diet, vitamins/ supplements 
Therapy Occupational therapy; physical therapy; speech and language therapy; early 
intervention; electronic speaking device; art therapy; music therapy; play 
therapy; dance therapy; sensory integration; counseling; sounds based 
treatments such as auditory training (AIT), Therapeutic Listening, Tomatis 
program, or Listening program; interactive metronome; animal assisted 
therapy with animals like a dog, cats, bird, rat; therapeutic riding; 
hippotherapy; manual therapy; sign language; social pragmatics approach; 
weighted vest or blanket; multisensory environments such as Snoezelen; 
holding therapy; assistive technology; integrated movement therapy; Bolles 
sensory learning; rapid prompting method; facilitated communication; 
exercise 
CAM Relaxation techniques such as deep breathing, yoga, acupuncture, Reiki, 
chiropractor, fortune teller/ palm reader, Buddhist monk interaction, 
hyperbaric oxygen chamber, craniosacral manipulation, massage, qigong, 
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transcranial stimulation, aromatherapy, Irlen lenses, Watsu, rolfing, 
marijuana, cannabinol oil (CBD/ hemp oil) 
Community Advocacy support, religious or spiritual support, autism support group, 
respite, job coaching, supported employment, transition services, sheltered 
workshop 
Behavioral Pivotal response training, psychotherapy, integrated behavioral therapy 
(IBT), applies behavioral analysis (ABA), positive behavioral support, 
positive reinforcement, negative reinforcement, discrete trial training, 
cognitive behavioral treatment, neurofeedback, early intensive behavioral 
treatment (EIBT), DIR floortime, antecedent-based intervention, cognitive 
behavioral intervention (CBI), behavioral specialist consultant (BSC), 
therapeutic staff support (TSS), cognitive enhancement therapy (CET, 
enriched supportive therapy (EST) 
Educational Option program; use of a resource room in school; SCERTS- social, 
communication, emotional regulation transactional support; modeling’ 
TEACCH method- treatment and education of autistic and related 
communication handicapped children; Denver model; social skills training; 
social interaction groups; Social Stories; picture exchange communication 
system (PECS); special education classroom; regular education classroom/ 
inclusive classroom/ mainstreamed; autism support classroom; behavior 
support classroom; learning support classroom; STAR program- strategies 
for teaching based on autism research; LEAP program preschool; Child Alert 
preschool; Head Start preschool; Pre-K program; Son-Rise program; 
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Montessori school; Individualized Family Service Plan (IFSP); 
Individualized Education Program (IEP); 1 on 1 aide in school; support 
services for school transportation; after school services; weekend school 
support services; visual schedule; Gentle teaching; Learning experiences and 
alternative program for preschoolers and parents; functional communication 
training, school-based occupational therapy; school-based speech therapy; 
school-based physical therapy; private special education school; life skills 
classroom; extended school year/ summer school; partial hospitalization 
program; responsive teaching curriculum (RT) 
 
 
 
 
 
 
 
